Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To determine the dose limiting toxicity and establish the maximal tolerated dose
2 years
No
Marisa Kollmeier, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
10-031
NCT01104350
April 2010
April 2017
Name | Location |
---|---|
Memorial Sloan Kettering Cancer Center | New York, New York 10021 |
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center | Sleepy Hollow, New York 10591 |
Memorial Sloan-Kettering at Basking Ridge | Basking Ridge, New Jersey 07920 |
Memorial Sloan-Kettering Cancer Center @ Suffolk | Commack, New York 11725 |
Memorial Sloan-Kettering at Mercy Medical Center | Rockville Centre, New York |